Healthcare -
Biotechnology - NASDAQ - US
$ 17.89
2.7 %
$ 544 M
Market Cap
-2.96
P/E
ANAB - SHORT-TERM INVESTMENTS
Short-term Investments ANAB - AnaptysBio, Inc.
355 M
LAST VALUE
160.34%
2 YEAR CAGR
2.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR